Status:

COMPLETED

Dapagliflozin After Transcatheter Aortic Valve Implantation

Lead Sponsor:

Spanish Society of Cardiology

Collaborating Sponsors:

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Conditions:

Aortic Stenosis

Transcatether Aortic Valve Implantation

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Pragmatic, controlled, prospective, randomized, open-label (open-label), evaluator-blind clinical trial (PROBE design) that will analyze the benefits of dapagliflozin treatment in patients with severe...

Detailed Description

Patients discharged after TAVI, with a history of heart failure (HF) plus depressed left ventricular ejection fraction (LVEF ≤ 40%) or diabetes mellitus (DM) or glomerular filtration rate (GFR) betwee...

Eligibility Criteria

Inclusion

  • SEVERE AORTIC STENOSIS UNDERWENT TAVI
  • PRIOR HEART FAILURE ADMISSION AND ONE OF THE FOLLOWING CRITERIA:
  • Left ventricular ejection fraction ≤ 40% or
  • Diabetes mellitus or
  • Estimated glomerular filtrate rate 25-75 ml/min/1.73 m2

Exclusion

  • Known allergy or intolerance to SGLT2 inhibitors.
  • Concomitant therapy with sulfonylurea or SGLT2 inhibitors..
  • Systolic blood pressure \< 100 mmHg or diastolic blood pressure \< 50 mmHg.
  • An estimated glomerular filtration rate (GFR) below 25 ml per minute per 1.73 m2.
  • Chronic cystitis and/or recurrent urinary tract infections (2 or more in the last year)
  • Poor control of diabetes mellitus that requires SGLT-2 inhibitor prescription on discharge according to treating physician judge.
  • Any medical condition that, in the investigator´s judgment, would seriously limit life expectancy (less than one year).
  • Pregnant or breast-feeding patients
  • Patients participating in other clinical trials.

Key Trial Info

Start Date :

January 27 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2024

Estimated Enrollment :

1257 Patients enrolled

Trial Details

Trial ID

NCT04696185

Start Date

January 27 2021

End Date

December 30 2024

Last Update

January 10 2025

Active Locations (40)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (40 locations)

1

Hospital Juan Canalejo

A Coruña, Spain

2

Hospital Universitario de Albacete

Albacete, Spain

3

Hospital General Universitario de Alicante

Alicante, Spain

4

Hospital Universitario de Cruces

Barakaldo, Spain